Evolus (EOLS) Short-term Investments (2019 - 2020)
Evolus (EOLS) reported Short-term Investments of $5.0 million for Q4 2020, down 74.89% on a YoY basis from $19.9 million in Q1 2020, and down 80.0% quarter-over-quarter from $25.0 million in Q3 2020.
Evolus (EOLS) Short-term Investments (2019 - 2020) Analysis & Trends
Evolus has reported Short-term Investments for 2 years, with the latest figure at $5.0 million in Q4 2020.
- For the quarter ending Q4 2020, Short-term Investments fell 74.89% year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2020 stood at $5.0 million (down 74.89% YoY), and the FY2020 full-year result was $5.0 million, down 74.89% from the prior year.
- Short-term Investments for Q4 2020 stood at $5.0 million, down from $25.0 million in the prior quarter.
- The five-year high for Short-term Investments was $79.3 million in Q1 2019, with the low at $5.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 5.00 Mn |
| Sep 30, 2020 | 25.00 Mn |
| Jun 30, 2020 | 54.98 Mn |
| Mar 31, 2020 | 64.99 Mn |
| Dec 31, 2019 | 19.91 Mn |
| Sep 30, 2019 | 34.91 Mn |
| Jun 30, 2019 | 69.64 Mn |
| Mar 31, 2019 | 79.31 Mn |